Enzalutamide
CAS 915087-33-1

In Stock
Enzalutamide
Cat. No. ANT-ELT-00CAS 915087-33-1In Stock
Technical Data
Cat. No.ANT-ELT-00
CAS915087-33-1
Mol. FormulaC21H16F4N4O2S
Mol. Weight464.44 g/mol
IUPAC4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-fluoro-N-methylbenzamide
SMILESCC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C
InChIInChI=1S/C21H16F4N4O2S/c1-20(2)18(31)28(12-5-4-11(10-26)15(8-12)21(23,24)25)19(32)29(20)13-6-7-14(16(22)9-13)17(30)27-3/h4-9H,1-3H3,(H,27,30)
InChI KeyWXCXUHSOUPDCQV-UHFFFAOYSA-N
PurityNA
Description
Overview
Enzalutamide, sold under the brand name Xtandi, is a nonsteroidal antiandrogen medication which is used in the treatment of prostate cancer
Anant Labs manufacture and furnish high quality Enzalutamide impurities for global markets. Our Enzalutamide EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamideEnzalutamide915087-33-1MDV3100MDV-31004-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-methylbenzamideMDV 3100XTANDIEnzalutamida93T0T9GKNU

















